Wordt geladen...
Chimeric antigen receptor T cell therapy for multiple myeloma
Chimeric antigen receptor (CAR) T cell therapy is a new cancer immunotherapy targeting cancer-specific cell surface antigen. CD19-CAR T cells have been already shown to be very effective to B cell leukemia/lymphoma. Now, many researchers are developing CAR T cells for multiple myeloma. CAR T cells t...
Bewaard in:
| Gepubliceerd in: | Inflamm Regen |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6547554/ https://ncbi.nlm.nih.gov/pubmed/31171941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41232-019-0100-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|